Pointe Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,038
| Closed | -$242K | – | 159 |
|
|
2024
Q1 | $242K | Hold |
3,038
| – | – | 0.15% | 139 |
|
|
2023
Q4 | $240K | Hold |
3,038
| – | – | 0.17% | 131 |
|
|
2023
Q3 | $212K | Hold |
3,038
| – | – | 0.16% | 129 |
|
|
2023
Q2 | $210K | Hold |
3,038
| – | – | 0.16% | 137 |
|
|
2023
Q1 | $226K | Sell |
3,038
-615
| -17% | -$51.6K | 0.16% | 134 |
|
|
2022
Q4 | $340K | Sell |
3,653
-205
| -5% | -$19.8K | 0.26% | 96 |
|
|
2022
Q3 | $368K | Hold |
3,858
| – | – | 0.29% | 89 |
|
|
2022
Q2 | $357K | Hold |
3,858
| – | – | 0.27% | 95 |
|
|
2022
Q1 | $390K | Hold |
3,858
| – | – | 0.25% | 103 |
|
|
2021
Q4 | $398K | Buy |
3,858
+43
| +1% | +$3.97K | 0.24% | 102 |
|
|
2021
Q3 | $324K | Hold |
3,815
| – | – | 0.22% | 108 |
|
|
2021
Q2 | $318K | Hold |
3,815
| – | – | 0.22% | 111 |
|
|
2021
Q1 | $287K | Buy |
3,815
+68
| +2% | +$4.95K | 0.2% | 117 |
|
|
2020
Q4 | $256K | Sell |
3,747
-835
| -18% | -$54.3K | 0.22% | 115 |
|
|
2020
Q3 | $266K | Hold |
4,582
| – | – | 0.23% | 108 |
|
|
2020
Q2 | $298K | Hold |
4,582
| – | – | 0.27% | 107 |
|
|
2020
Q1 | $272K | Hold |
4,582
| – | – | 0.26% | 98 |
|
|
2019
Q4 | $340K | Hold |
4,582
| – | – | 0.29% | 100 |
|
|
2019
Q3 | $289K | Hold |
4,582
| – | – | 0.24% | 109 |
|
|
2019
Q2 | $250K | Sell |
4,582
-164
| -3% | -$8.83K | 0.21% | 123 |
|
|
2019
Q1 | $256K | Sell |
4,746
-2,288
| -33% | -$141K | 0.22% | 124 |
|
|
2018
Q4 | $461K | Sell |
7,034
-128
| -2% | -$9.55K | 0.45% | 69 |
|
|
2018
Q3 | $564K | Buy |
7,162
+822
| +13% | +$58.8K | 0.44% | 64 |
|
|
2018
Q2 | $408K | Buy |
6,340
+153
| +2% | +$10.1K | 0.35% | 88 |
|
|
2018
Q1 | $385K | Buy |
6,187
+24
| +0.4% | +$1.72K | 0.33% | 94 |
|
|
2017
Q4 | $447K | Sell |
6,163
-112
| -2% | -$8.14K | 0.36% | 82 |
|
|
2017
Q3 | $510K | Buy |
6,275
+9
| +0.1% | +$712 | 0.38% | 81 |
|
|
2017
Q2 | $504K | Sell |
6,266
-594
| -9% | -$46.9K | 0.36% | 82 |
|
|
2017
Q1 | $538K | Buy |
+6,860
| New | +$548K | 0.41% | 72 |
|
|
2016
Q4 | – | Sell |
-7,582
| Closed | -$675K | – | 170 |
|
|
2016
Q3 | $675K | Sell |
7,582
-184
| -2% | -$17.4K | 0.49% | 58 |
|
|
2016
Q2 | $744K | Sell |
7,766
-479
| -6% | -$47.7K | 0.54% | 55 |
|
|
2016
Q1 | $855K | Buy |
8,245
+57
| +0.7% | +$5.54K | 0.68% | 43 |
|
|
2015
Q4 | $801K | Buy |
8,188
+1,027
| +14% | +$101K | 0.58% | 51 |
|
|
2015
Q3 | $691K | Buy |
7,161
+1,104
| +18% | +$116K | 0.42% | 66 |
|
|
2015
Q2 | $635K | Buy |
6,057
+1,805
| +42% | +$184K | 0.29% | 76 |
|
|
2015
Q1 | $439K | Buy |
+4,252
| New | +$430K | 0.21% | 93 |
|
Other funds holding CVS
Pointe Capital Management's CVS Position: Q2 2024 in Review
Pointe Capital Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,038 shares — an estimated $242K sold.
Pointe Capital Management first reported a position in CVS in Q1 2015 and held it in 36 quarters. The position peaked at $855K in Q1 2016. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Pointe Capital Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Pointe Capital Management sold 3,038 CVS Health shares in Q2 2024, an estimated $242K.
- Pointe Capital Management first reported a position in CVS Health in Q1 2015 and held it in 36 quarters.
- Pointe Capital Management's CVS Health position peaked at $855K in Q1 2016.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Pointe Capital Management's 13F filing for Q2 2024, filed 12 Jul 2024.